WESTBROOK, Maine, April 25, 2014 /PRNewswire/ -- IDEXX Laboratories, Inc. /quotes/zigman/73621/delayed/quotes/nls/idxx IDXX +0.02% today reported that revenues for the first quarter of 2014 increased 8% versus the prior year period to $360.2 million. Organic revenue growth1 was also 8%. Earnings per diluted share (“EPS”) for the quarter ended March 31, 2014 increased 10% from the prior year period to $0.89. The first quarter of 2013 included the retroactive extension of the federal research and development tax credit, and the associated tax benefit related to that quarter, which added $0.06 to first quarter 2013 EPS, and a loss resulting from a third-party service provider’s bankruptcy, which reduced first quarter 2013 EPS by $0.05. As the research and development tax credit expired as of January 1, 2014, no benefit from this provision was included in first quarter 2014 results.
Help employers find you! Check out all the jobs and post your resume.
